{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:45:01Z","timestamp":1782794701468,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of Clinical Key Subject Construction of Shanghai","award":["shslczdzk06504"],"award-info":[{"award-number":["shslczdzk06504"]}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"crossref","award":["No.202240293"],"award-info":[{"award-number":["No.202240293"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"crossref","award":["No.20244Y0101"],"award-info":[{"award-number":["No.20244Y0101"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.82204520"],"award-info":[{"award-number":["NO.82204520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai \"Rising Stars of Medical Talent\" Youth Development Program Youth Medical Talents \u2013 Clinical Pharmacist Program","award":["SHWSRS (2023)106"],"award-info":[{"award-number":["SHWSRS (2023)106"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-026-07596-3","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:25:13Z","timestamp":1778149513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vancomycin\u2013induced acute kidney injury in older Chinese patients: a multicenter retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunhui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchun","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzhou","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"4","key":"7596_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/phar.2376","volume":"40","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Executive summary: therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2020;40(4):363\u20137.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"7596_CR2","doi-asserted-by":"publisher","first-page":"dlaa114","DOI":"10.1093\/jacamr\/dlaa114","volume":"3","author":"NM Brown","year":"2021","unstructured":"Brown NM, Goodman AL, Horner C, Jenkins A, Brown EM. Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. JAC Antimicrob Resist. 2021;3(1):dlaa114.","journal-title":"JAC Antimicrob Resist"},{"issue":"Suppl 4","key":"7596_CR3","doi-asserted-by":"publisher","first-page":"S363","DOI":"10.1093\/cid\/ciaa1536","volume":"71","author":"N He","year":"2020","unstructured":"He N, Su S, Ye Z, Du G, He B, Li D, et al. Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. Clin Infect Dis. 2020;71(Suppl 4):S363\u201371.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"7596_CR4","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1007\/s11096-018-0634-8","volume":"40","author":"SJ Park","year":"2018","unstructured":"Park SJ, Lim NR, Park HJ, Yang JW, Kim MJ, Kim K, et al. Evaluation of risk factors for vancomycin-induced nephrotoxicity. Int J Clin Pharm. 2018;40(5):1328\u201334.","journal-title":"Int J Clin Pharm"},{"key":"7596_CR5","doi-asserted-by":"publisher","first-page":"7685","DOI":"10.2147\/IJGM.S380017","volume":"15","author":"P Wagner","year":"2022","unstructured":"Wagner P, Arnold J, Sheridan K. Vancomycin loading doses and nephrotoxicity on medicine teaching services. Int J Gen Med. 2022;15:7685\u201392.","journal-title":"Int J Gen Med"},{"issue":"4","key":"7596_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.3390\/ijms23042052","volume":"23","author":"WC Kan","year":"2022","unstructured":"Kan WC, Chen YC, Wu VC, Shiao CC. Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application. Int J Mol Sci. 2022;23(4):2052.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7596_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01568-12","volume":"57","author":"SJ van Hal","year":"2013","unstructured":"van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013;57(2):734\u201344.","journal-title":"Antimicrob Agents Chemother"},{"key":"7596_CR8","doi-asserted-by":"publisher","first-page":"632107","DOI":"10.3389\/fphar.2021.632107","volume":"12","author":"P Kunming","year":"2021","unstructured":"Kunming P, Can C, Zhangzhang C, Wei W, Qing X, Xiaoqiang D, et al. Vancomycin associated acute kidney injury: a longitudinal study in China. Front Pharmacol. 2021;12:632107.","journal-title":"Front Pharmacol"},{"issue":"4","key":"7596_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/600884","volume":"49","author":"TP Lodise","year":"2009","unstructured":"Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009;49(4):507\u201314.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7596_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/AAC.01653-13","volume":"58","author":"MN Neely","year":"2014","unstructured":"Neely MN, Youn G, Jones B, Jelliffe RW, Drusano GL, Rodvold KA, et al. Are vancomycin trough concentrations adequate for optimal dosing? Antimicrob Agents Chemother. 2014;58(1):309\u201316.","journal-title":"Antimicrob Agents Chemother"},{"key":"7596_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2017.02.025","volume":"800","author":"Y Sakamoto","year":"2017","unstructured":"Sakamoto Y, Yano T, Hanada Y, Takeshita A, Inagaki F, Masuda S, et al. Vancomycin induces reactive oxygen species-dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells. Eur J Pharmacol. 2017;800:48\u201356.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"7596_CR12","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1128\/AAC.04132-14","volume":"59","author":"A Glatare","year":"2015","unstructured":"Glatare A, Bourguignon L, Jelliffe RW, Maire P, Neely MN, Goutelle S. Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients. Antimicrob Agents Chemother. 2015;59(6):2986\u201394.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"7596_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/genes13050796","volume":"13","author":"F Liu","year":"2022","unstructured":"Liu F, Chen J, Li Z, Meng X. Recent advances in epigenetics of age-related kidney diseases. Genes (Basel). 2022;13(5):796.","journal-title":"Genes (Basel)"},{"issue":"1","key":"7596_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.suc.2014.09.003","volume":"95","author":"AJ Baldea","year":"2015","unstructured":"Baldea AJ. Effect of aging on renal function plus monitoring and support. Surg Clin North Am. 2015;95(1):71\u201383.","journal-title":"Surg Clin North Am"},{"key":"7596_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejca.2017.05.044","volume":"82","author":"A Daste","year":"2017","unstructured":"Daste A, Domblides C, Gross-Goupil M, Chakiba C, Quivy A, Cochin V, et al. Immune checkpoint inhibitors and elderly people: a review. Eur J Cancer. 2017;82:155\u201366.","journal-title":"Eur J Cancer"},{"issue":"Suppl 19","key":"7596_CR16","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.5301\/jn.5000141","volume":"25","author":"A Del Giudice","year":"2012","unstructured":"Del Giudice A, Aucella F. Acute renal failure in the elderly: epidemiology and clinical features. J Nephrol. 2012;25(Suppl 19):S48\u201357.","journal-title":"J Nephrol"},{"issue":"4","key":"7596_CR17","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384.","journal-title":"Nephron Clin Pract"},{"issue":"8","key":"7596_CR18","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/bcp.13594","volume":"84","author":"KM Pan","year":"2018","unstructured":"Pan KM, Wu Y, Chen C, Chen ZZ, Xu JA, Cao L, et al. Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study. Br J Clin Pharmacol. 2018;84(8):1706\u201318.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"7596_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jcph.6130","volume":"65","author":"R Ruiz-Gaviria","year":"2025","unstructured":"Ruiz-Gaviria R, Norman SJ, Elgendi SH, Chou J, Ramdeen S. Incidence of acute kidney injury in trough and AUC\/MIC vancomycin dosing strategies in a large tertiary care center: a retrospective cohort. J Clin Pharmacol. 2025;65(2):190\u20136.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"7596_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/sj.ki.5002297","volume":"72","author":"CY Hsu","year":"2007","unstructured":"Hsu CY, McCulloch CE, Fan D, Ordo\u00f1ez JD, Chertow GM, Go AS. Community-based incidence of acute renal failure. Kidney Int. 2007;72(2):208\u201312.","journal-title":"Kidney Int"},{"issue":"4","key":"7596_CR21","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1681\/ASN.2005060668","volume":"17","author":"JL Xue","year":"2006","unstructured":"Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17(4):1135\u201342.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"7596_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1681\/ASN.2006070756","volume":"18","author":"T Ali","year":"2007","unstructured":"Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18(4):1292\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"7596_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.ajkd.2009.12.034","volume":"56","author":"SG Coca","year":"2010","unstructured":"Coca SG. Acute kidney injury in elderly persons. Am J Kidney Dis. 2010;56(1):122\u201331.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"7596_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/bcp.15301","volume":"89","author":"P Kunming","year":"2023","unstructured":"Kunming P, Xiaotian J, Qing X, Chenqi X, Xiaoqiang D, Qian Zhou L. Impact of pharmacist intervention in reducing vancomycin-associated acute kidney injury: a systematic review and meta-analysis. Br J Clin Pharmacol. 2023;89(2):526\u201335.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"7596_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12879-024-09227-x","volume":"24","author":"J Chen","year":"2024","unstructured":"Chen J, Lin J, Weng J, Ju Y, Li Y. Association between trough serum vancomycin concentration and vancomycin-associated acute kidney injury and 30-day mortality in critically ill elderly adults. BMC Infect Dis. 2024;24(1):330.","journal-title":"BMC Infect Dis"},{"issue":"19","key":"7596_CR26","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"LK Hidayat","year":"2006","unstructured":"Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006;166(19):2138\u201344.","journal-title":"Arch Intern Med"},{"issue":"11","key":"7596_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s10157-024-02512-8","volume":"28","author":"Y Hatakeyama","year":"2024","unstructured":"Hatakeyama Y, Horino T, Yasui S, Terada Y, Okuhara Y. Differences in characteristics and risk factors for acute kidney injury between elderly and very elderly patients: a retrospective review. Clin Exp Nephrol. 2024;28(11):1097\u2013110.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"7596_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12882-016-0351-2","volume":"17","author":"S Ge","year":"2016","unstructured":"Ge S, Nie S, Liu Z, Chen C, Zha Y, Qian J, et al. Epidemiology and outcomes of acute kidney injury in elderly chinese patients: a subgroup analysis from the EACH study. BMC Nephrol. 2016;17(1):136.","journal-title":"BMC Nephrol"},{"issue":"5\u20136","key":"7596_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000381783","volume":"95","author":"Y Liu","year":"2015","unstructured":"Liu Y, Yin Y, Liu XZ, Yao HJ, Li LX, Chen JH, et al. Retrospective analysis of vancomycin nephrotoxicity in elderly Chinese patients. Pharmacology. 2015;95(5\u20136):279\u201384.","journal-title":"Pharmacology"},{"issue":"4","key":"7596_CR30","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1128\/AAC.01602-07","volume":"52","author":"TP Lodise","year":"2008","unstructured":"Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008;52(4):1330\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"7596_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.294.7.813","volume":"294","author":"S Uchino","year":"2005","unstructured":"Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813\u20138.","journal-title":"JAMA"},{"issue":"1","key":"7596_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/sur.2015.104","volume":"17","author":"SW Davies","year":"2016","unstructured":"Davies SW, Efird JT, Guidry CA, Dietch ZC, Willis RN, Shah PM, et al. Top guns: The Maverick and Goose of empiric therapy. Surg Infect (Larchmt). 2016;17(1):38\u201347.","journal-title":"Surg Infect (Larchmt)"},{"issue":"3","key":"7596_CR33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/jac\/dkae001","volume":"79","author":"BM Tomazini","year":"2024","unstructured":"Tomazini BM, Besen B, Taniguchi LU, Zampieri FG, Cavalcanti AB. Association between piperacillin\/tazobactam use and acute kidney injury in critically ill patients: a retrospective multicentre cohort study. J Antimicrob Chemother. 2024;79(3):552\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"7596_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chest.2023.03.046","volume":"164","author":"AY Chen","year":"2023","unstructured":"Chen AY, Deng CY, Calvachi-Prieto P, Armengol de la Hoz M, Khazi-Syed A, Chen C, et al. A large-scale multicenter retrospective study on nephrotoxicity associated with empiric broad-spectrum antibiotics in critically ill patients. Chest. 2023;164(2):355\u201368.","journal-title":"Chest"},{"issue":"7","key":"7596_CR35","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/phar.1442","volume":"34","author":"LD Burgess","year":"2014","unstructured":"Burgess LD, Drew RH. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Pharmacotherapy. 2014;34(7):670\u20136.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"7596_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/cid\/ciz1189","volume":"71","author":"SN Avedissian","year":"2020","unstructured":"Avedissian SN, Pais GM, Liu J, Rhodes NJ, Scheetz MH. Piperacillin-tazobactam added to vancomycin increases risk for acute kidney injury: fact or fiction? Clin Infect Dis. 2020;71(2):426\u201332.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"7596_CR37","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/00003246-200206000-00013","volume":"30","author":"L Le Moyec","year":"2002","unstructured":"Le Moyec L, Racine S, Le Toumelin P, Adnet F, Larue V, Cohen Y, et al. Aminoglycoside and glycopeptide renal toxicity in intensive care patients studied by proton magnetic resonance spectroscopy of urine. Crit Care Med. 2002;30(6):1242\u20135.","journal-title":"Crit Care Med"},{"issue":"8","key":"7596_CR38","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411\u201323.","journal-title":"Intensive Care Med"},{"issue":"1","key":"7596_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58\u201366.","journal-title":"N Engl J Med"},{"issue":"7","key":"7596_CR40","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1093\/ndt\/gfn090","volume":"23","author":"J Luo","year":"2008","unstructured":"Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transpl. 2008;23(7):2198\u2013205.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"7596_CR41","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1742-7843.2007.00051.x","volume":"100","author":"S Ocak","year":"2007","unstructured":"Ocak S, Gorur S, Hakverdi S, Celik S, Erdogan S. Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol. 2007;100(5):328\u201333.","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07596-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07596-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07596-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:10:11Z","timestamp":1782792611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07596-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7596"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07596-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7534336\/v1","asserted-by":"object"}]},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study rigorously followed the ethical principles set forth in the Declaration of Helsinki. Ethical approval was obtained from all participating institutions, including the Ethics Committee of Zhongshan Hospital, Fudan University (No. B2024\u2013451(2)), the Ethics Committee of Tongji Hospital, Tongji University (No. K\u20132025\u2013024), and the Ethics Committee of Shanghai Changzheng Hospital (No. 2025SL058). Informed consent was waived for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"880"}}